Delivering value-based oncology care requires both scientific breakthroughs and deliberate system redesign, experts concurred ...

The field of thoracic oncology has undergone a significant transformation with the integration of next-generation genomic profiling technologies.

Q4 2025 Earnings Call Transcript March 23, 2026Bionano Genomics, Inc. reports earnings inline with expectations.

The droppings contain DNA, he thought, and perhaps, even after rain washes them away, some DNA might remain. And if it does ...

A $4.7 million collaboration led by the National Cancer Centre Singapore will develop a clinical-grade test using AI and ...

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.

After years of operating in the research markets, IDT has launched IVD assays based on the core chemistry capabilities from the company's Archer portfolio.

Wastewater — a sanitized name for human fecal matter and urine — tells the story, providing evidence even before the symptoms ...

Liquid biopsies are expanding: Blood tests that can detect cancer are moving beyond just late-stage treatment selection. They ...

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

Practice-changing data in endometrial cancer support checkpoint inhibitor–chemotherapy combinations, extending ...